- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Opioids Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Opioids Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Opioids Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Hospira
Purdue Pharma
Pfizer
Johnson & Johnson
AbbVie
Allergan
Teva pharmaceuticals
Orexo Pharmaceuticals
Sanofi-aventis US LLC
Endo Pharmaceuticals
By Type:
Oxycodone (e.g., OxyContin, Percocet)
Hydrocodone (e.g., Vicodin)
Codeine
Morphine (e.g., Kadian, Avinza)
Others
By End-User:
Neuropathic pain treatment
Orthopedic pain treatment
Other pain treatment
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioids Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Opioids Drugs Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) from 2014 to 2026
1.3.2 Japan Opioids Drugs Market Size and Growth Rate of Hydrocodone (e.g., Vicodin) from 2014 to 2026
1.3.3 Japan Opioids Drugs Market Size and Growth Rate of Codeine from 2014 to 2026
1.3.4 Japan Opioids Drugs Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza) from 2014 to 2026
1.3.5 Japan Opioids Drugs Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Opioids Drugs Market Size and Growth Rate of Neuropathic pain treatment from 2014 to 2026
1.4.2 Japan Opioids Drugs Market Size and Growth Rate of Orthopedic pain treatment from 2014 to 2026
1.4.3 Japan Opioids Drugs Market Size and Growth Rate of Other pain treatment from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Opioids Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Opioids Drugs by Major Types
3.4.1 Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet)
3.4.2 Market Size and Growth Rate of Hydrocodone (e.g., Vicodin)
3.4.3 Market Size and Growth Rate of Codeine
3.4.4 Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza)
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Opioids Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Opioids Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Opioids Drugs in Neuropathic pain treatment
4.4.2 Market Size and Growth Rate of Opioids Drugs in Orthopedic pain treatment
4.4.3 Market Size and Growth Rate of Opioids Drugs in Other pain treatment
5 Market Analysis by Regions
-
5.1 Japan Opioids Drugs Production Analysis by Regions
-
5.2 Japan Opioids Drugs Consumption Analysis by Regions
6 Hokkaido Opioids Drugs Landscape Analysis
-
6.1 Hokkaido Opioids Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Opioids Drugs Landscape Analysis by Major End-Users
7 Tohoku Opioids Drugs Landscape Analysis
-
7.1 Tohoku Opioids Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Opioids Drugs Landscape Analysis by Major End-Users
8 Kanto Opioids Drugs Landscape Analysis
-
8.1 Kanto Opioids Drugs Landscape Analysis by Major Types
-
8.2 Kanto Opioids Drugs Landscape Analysis by Major End-Users
9 Chubu Opioids Drugs Landscape Analysis
-
9.1 Chubu Opioids Drugs Landscape Analysis by Major Types
-
9.2 Chubu Opioids Drugs Landscape Analysis by Major End-Users
10 Kinki Opioids Drugs Landscape Analysis
-
10.1 Kinki Opioids Drugs Landscape Analysis by Major Types
-
10.2 Kinki Opioids Drugs Landscape Analysis by Major End-Users
11 Chugoku Opioids Drugs Landscape Analysis
-
11.1 Chugoku Opioids Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Opioids Drugs Landscape Analysis by Major End-Users
12 Shikoku Opioids Drugs Landscape Analysis
-
12.1 Shikoku Opioids Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Opioids Drugs Landscape Analysis by Major End-Users
13 Kyushu Opioids Drugs Landscape Analysis
-
13.1 Kyushu Opioids Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Opioids Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Hospira
14.1.1 Hospira Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Purdue Pharma
14.2.1 Purdue Pharma Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Pfizer
14.3.1 Pfizer Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Johnson & Johnson
14.4.1 Johnson & Johnson Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 AbbVie
14.5.1 AbbVie Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Allergan
14.6.1 Allergan Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Teva pharmaceuticals
14.7.1 Teva pharmaceuticals Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Orexo Pharmaceuticals
14.8.1 Orexo Pharmaceuticals Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Sanofi-aventis US LLC
14.9.1 Sanofi-aventis US LLC Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Endo Pharmaceuticals
14.10.1 Endo Pharmaceuticals Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 131 Figures and 132 Tables)
Figure Japan Opioids Drugs Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet) from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Hydrocodone (e.g., Vicodin) from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Codeine from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza) from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Neuropathic pain treatment from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Orthopedic pain treatment from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Other pain treatment from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Opioids Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Opioids Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Opioids Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Opioids Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Opioids Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Oxycodone (e.g., OxyContin, Percocet)
Figure Market Size and Growth Rate of Hydrocodone (e.g., Vicodin)
Figure Market Size and Growth Rate of Codeine
Figure Market Size and Growth Rate of Morphine (e.g., Kadian, Avinza)
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Opioids Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Opioids Drugs by Different End-Users from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Neuropathic pain treatment from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Orthopedic pain treatment from 2014 to 2026
Figure Japan Opioids Drugs Market Size and Growth Rate of Other pain treatment from 2014 to 2026
-
Table Japan Opioids Drugs Production by Regions
-
Table Japan Opioids Drugs Production Share by Regions
-
Figure Japan Opioids Drugs Production Share by Regions in 2014
-
Figure Japan Opioids Drugs Production Share by Regions in 2018
-
Figure Japan Opioids Drugs Production Share by Regions in 2026
-
Table Japan Opioids Drugs Consumption by Regions
-
Table Japan Opioids Drugs Consumption Share by Regions
-
Figure Japan Opioids Drugs Consumption Share by Regions in 2014
-
Figure Japan Opioids Drugs Consumption Share by Regions in 2018
-
Figure Japan Opioids Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Opioids Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Opioids Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Opioids Drugs Consumption Share by Types in 2026
-
Table Hokkaido Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Opioids Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Opioids Drugs Consumption Share by Types in 2014
-
Figure Tohoku Opioids Drugs Consumption Share by Types in 2018
-
Figure Tohoku Opioids Drugs Consumption Share by Types in 2026
-
Table Tohoku Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Opioids Drugs Consumption Share by End-Users in 2026
-
Table Kanto Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Opioids Drugs Consumption Share by Types in 2014
-
Figure Kanto Opioids Drugs Consumption Share by Types in 2018
-
Figure Kanto Opioids Drugs Consumption Share by Types in 2026
-
Table Kanto Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Opioids Drugs Consumption Share by End-Users in 2026
-
Table Chubu Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Opioids Drugs Consumption Share by Types in 2014
-
Figure Chubu Opioids Drugs Consumption Share by Types in 2018
-
Figure Chubu Opioids Drugs Consumption Share by Types in 2026
-
Table Chubu Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Opioids Drugs Consumption Share by End-Users in 2026
-
Table Kinki Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Opioids Drugs Consumption Share by Types in 2014
-
Figure Kinki Opioids Drugs Consumption Share by Types in 2018
-
Figure Kinki Opioids Drugs Consumption Share by Types in 2026
-
Table Kinki Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Opioids Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Opioids Drugs Consumption Share by Types in 2014
-
Figure Chugoku Opioids Drugs Consumption Share by Types in 2018
-
Figure Chugoku Opioids Drugs Consumption Share by Types in 2026
-
Table Chugoku Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Opioids Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Opioids Drugs Consumption Share by Types in 2014
-
Figure Shikoku Opioids Drugs Consumption Share by Types in 2018
-
Figure Shikoku Opioids Drugs Consumption Share by Types in 2026
-
Table Shikoku Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Opioids Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Opioids Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Opioids Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Opioids Drugs Consumption Share by Types in 2014
-
Figure Kyushu Opioids Drugs Consumption Share by Types in 2018
-
Figure Kyushu Opioids Drugs Consumption Share by Types in 2026
-
Table Kyushu Opioids Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Opioids Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Opioids Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Opioids Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Opioids Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Hospira
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
Figure Sales and Growth Rate Analysis of Hospira
Figure Revenue and Market Share Analysis of Hospira
Table Product and Service Introduction of Hospira
Table Company Profile and Development Status of Purdue Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma
Figure Sales and Growth Rate Analysis of Purdue Pharma
Figure Revenue and Market Share Analysis of Purdue Pharma
Table Product and Service Introduction of Purdue Pharma
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of Allergan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
Figure Sales and Growth Rate Analysis of Allergan
Figure Revenue and Market Share Analysis of Allergan
Table Product and Service Introduction of Allergan
Table Company Profile and Development Status of Teva pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva pharmaceuticals
Figure Sales and Growth Rate Analysis of Teva pharmaceuticals
Figure Revenue and Market Share Analysis of Teva pharmaceuticals
Table Product and Service Introduction of Teva pharmaceuticals
Table Company Profile and Development Status of Orexo Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexo Pharmaceuticals
Figure Sales and Growth Rate Analysis of Orexo Pharmaceuticals
Figure Revenue and Market Share Analysis of Orexo Pharmaceuticals
Table Product and Service Introduction of Orexo Pharmaceuticals
Table Company Profile and Development Status of Sanofi-aventis US LLC
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-aventis US LLC
Figure Sales and Growth Rate Analysis of Sanofi-aventis US LLC
Figure Revenue and Market Share Analysis of Sanofi-aventis US LLC
Table Product and Service Introduction of Sanofi-aventis US LLC
Table Company Profile and Development Status of Endo Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals
Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals
Figure Revenue and Market Share Analysis of Endo Pharmaceuticals
Table Product and Service Introduction of Endo Pharmaceuticals
-